TAPUR Study - FDA approved therapies Targeted therapies such as BRAF, CDK2NA, etc. - 100459

Spotlight
Video

TAPUR Study - FDA approved therapies Targeted therapies such as BRAF, CDK2NA, etc.

moasc has 333 videos Subscribe Here

Loading........
Description: Omid Hamid MD
Chief, Translational Research/Immuno-Oncology
Director shares, TAPUR Study - FDA approved therapies Targeted therapies such as BRAF, CDK2NA, etc. at the 2018 Oncology Summit in Huntington Beach, CA

Go to: http://www.moasc.org... for more information
Shared By : moasc
Posted on : 03/08/18
Added : 9 months ago



Recommended

Nothing found.